CD274 and neoplasm: The genomic profiling of these patients demonstrated features classically associated with increased responses to CPIs, including a high programmed death ligand 1 (PD-L1) expression, high tumor mutational burden (TMB), high microsatellite instability (MSI-high), and deficient mismatch repair genes (dMMRs) [3,4,6].